On July 30, Altria declined 6.18% in regular trading, trading at $68.875/share, with turnover of $255 million. The sell-off was triggered by the company's Q2 earnings report released pre-market.

Altria reported Q2 adjusted EPS of $1.48, missing the analyst consensus estimate of $1.50 by 1.33%. Revenue came in at $6.11 billion, beating the $5.35 billion estimate. However, the volume picture revealed significant deterioration in product mix: premium brand Marlboro shipments fell 7.4%, On! nicotine pouch shipments declined 4.2%, while discount cigarette shipments surged 67.3%, reflecting persistent economic pressure driving consumers toward lower-priced alternatives.

Management noted on the earnings call that economic headwinds continue to reshape the cigarette industry landscape. The company narrowed its full-year adjusted EPS guidance to $5.61-$5.72, raising the lower bound from $5.56 previously, with the midpoint roughly in line with the FactSet consensus of $5.69. Despite revenue beating expectations and guidance being maintained, the EPS miss combined with unfavorable product mix shift weighed heavily on shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)